Literature DB >> 1798888

A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

M W Johns1.   

Abstract

The development and use of a new scale, the Epworth sleepiness scale (ESS), is described. This is a simple, self-administered questionnaire which is shown to provide a measurement of the subject's general level of daytime sleepiness. One hundred and eighty adults answered the ESS, including 30 normal men and women as controls and 150 patients with a range of sleep disorders. They rated the chances that they would doze off or fall asleep when in eight different situations commonly encountered in daily life. Total ESS scores significantly distinguished normal subjects from patients in various diagnostic groups including obstructive sleep apnea syndrome, narcolepsy and idiopathic hypersomnia. ESS scores were significantly correlated with sleep latency measured during the multiple sleep latency test and during overnight polysomnography. In patients with obstructive sleep apnea syndrome ESS scores were significantly correlated with the respiratory disturbance index and the minimum SaO2 recorded overnight. ESS scores of patients who simply snored did not differ from controls.

Entities:  

Mesh:

Year:  1991        PMID: 1798888     DOI: 10.1093/sleep/14.6.540

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  2000 in total

1.  Primary Care: Is It the Setting to Address Sleep Disorders?

Authors:  William C. Dement; Nikolaus C. Netzer
Journal:  Sleep Breath       Date:  2000       Impact factor: 2.816

2.  Drowsiness, counter-measures to drowsiness, and the risk of a motor vehicle crash.

Authors:  P Cummings; T D Koepsell; J M Moffat; F P Rivara
Journal:  Inj Prev       Date:  2001-09       Impact factor: 2.399

Review 3.  The sleepy patient.

Authors:  N J Douglas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

4.  Driver sleepiness and risk of serious injury to car occupants: population based case control study.

Authors:  Jennie Connor; Robyn Norton; Shanthi Ameratunga; Elizabeth Robinson; Ian Civil; Roger Dunn; John Bailey; Rod Jackson
Journal:  BMJ       Date:  2002-05-11

5.  Health and socioeconomic status differences among antibody hepatitis C positive and negative transfusion recipients, 1986-1990.

Authors:  Robert S Hogg; Kevin J P Craib; David Pi; Samuel S Lee; Gerald Y Minuk; Colin M Shapiro; Martin T Schechter; Michael V O'Shaughnessy
Journal:  Can J Public Health       Date:  2003 Mar-Apr

6.  Validation of a Chinese version of the Epworth sleepiness scale.

Authors:  Ning-Hung Chen; Murray W Johns; Hseuh-Yu Li; Chia-Chen Chu; Shu-Cheng Liang; Yu-Hsiang Shu; Ming-Lung Chuang; Pa-Chun Wang
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

7.  The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease.

Authors:  K R Chaudhuri; S Pal; A DiMarco; C Whately-Smith; K Bridgman; R Mathew; F R Pezzela; A Forbes; B Högl; C Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

8.  The Evolution of Sleep Apnea Six Months After Acute Ischemic Stroke and Thrombolysis.

Authors:  Jaana K Huhtakangas; Tarja Saaresranta; Risto Bloigu; Juha Huhtakangas
Journal:  J Clin Sleep Med       Date:  2018-12-15       Impact factor: 4.062

9.  Diabetes sleep treatment trial: Premise, design, and methodology.

Authors:  Eileen R Chasens; Charles W Atwood; Lora E Burke; Mary Korytkowski; Robert Stansbury; Patrick J Strollo; Susan M Sereika
Journal:  Contemp Clin Trials       Date:  2018-12-02       Impact factor: 2.226

10.  Long Sleep Duration, Insomnia, and Insomnia With Short Objective Sleep Duration Are Independently Associated With Short Telomere Length.

Authors:  Priscila Tempaku; Camila Hirotsu; Diego Mazzotti; Gabriela Xavier; Pawan Maurya; Elisa Brietzke; Sintia Belangero; Dalva Poyares; Lia Bittencourt; Sergio Tufik
Journal:  J Clin Sleep Med       Date:  2018-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.